#UNICHEMLAB : SHORT TERM UPTREND RECOMMENDATION : UNICHEMLAB. Watch this stock for short term / long term investment. maintain stoploss at 10% trailing basis. This is looking super bullish for holding players
For the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 2377 crore, up 8.69 per cent from last quarter total income of Rs 2187 crore and up 9.34 per cent from last year same quarter total income of Rs 2174 crore.
The transaction will see the exit of existing investors of Curatio, such as ChrysCapital (which holds a 20% stake) and Sequoia Capital (33%). Promoters, including GK Ramani, and the management will also be exiting the company.
The drug firm had reported a net loss of Rs 11 crore in the April-June period of last fiscal.Total income for the period under review stood at Rs 317 crore as compared with Rs 314 crore in the year-ago period, Unichem Laboratories said in a regulatory filing.
Torrent Pharma appoints Aman Mehta as Director on its Board
"At Torrent Power, Aman was involved at a challenging point in the business journey and was instrumental in bringing about a customer orientation transformation within the distribution business and also made noteworthy contributions in enhancing efficiency in operations," the company said.
Torrent Pharma posts Rs 354 cr net profit in Q1FY23, appoints Aman Mehta on the board
"Further, he has led several organic growth initiatives that have started delivering market share gains, with a focus on new product launches. Aman is a key contributor in the evaluation of acquisition opportunities and driving the strategic direction of India business," the company said.
The company last month had received Abbreviated New Drug Application approval from the US Food and Drug Administration (USFDA) for Aripiprazole tablets USP; a development that had sent its share price soaring.
Unichem Laboratories Q1 results: Company posts net loss of Rs 11.48 cr
Drug firm Unichem Laboratories on Saturday reported a consolidated net loss of Rs 11.48 crore for the quarter ended on June 30, 2021. The company had posted a net profit of Rs 2.43 crore for the corresponding period of the previous fiscal, Unichem Labs said in a regulatory filing.
Wipro: The company has signed an agreement to acquire Capco, a global management and technology consultancy providing digital, consulting and technology services to financial institutions in America, Europe and the Asia Pacific.
Unichem Laboratories Gets USFDA Nod For Plaque Psoriasis Treatment Drug
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drug
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Unichem Laboratories Gets USFDA Nod To Market Generic Capsules
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
Unichem Labs gets USFDA nod to market generic capsules
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
Unichem Laboratories Gets USFDA Nod To Market Generic Celecoxib Capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
Pharma is in focus but there is no valuation comfort: Prabhudas Lilladher
‘We have a buy on Dr Reddys and Lupin. Dr Reddys definitely has a positive but the valuation remains very challenging after this recent run up of Rs 1,000 or more.
Need to boost local API production for India to become self-reliant in coming years: Unichem Laboratories
Sharing information with shareholders in company's annual report for 2019-20, the drug firm said the ongoing coronavirus pandemic calls for concentrated efforts to build upon capacities for active pharmaceutical ingredients (APIs) in the country.
Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat
Drug firm Unichem Laboratories on Wednesday said it has received approval from the US health regulator for its Amiodarone tablets used to treat irregular heartbeat. The approved product is a generic version of Wyeth Pharmaceuticals Inc's Cordarone tablets.